Project Title
Pediatric Phase 2 Studies Using Indoximod with Chemotherapy and Radiation for Children with Advanced Brain Cancer
Layman’s summary
This new, Phase 2 study, tests the hypothesis that treatment with indoximod will enhance the effects of conventional chemotherapy and radiation in children with recurrent brain tumors, or with newly-diagnosed DIPG. It also includes a compassionate-use study that provides indoximod-based therapy to children and young adults with progressive brain cancer who would otherwise not qualify for the Phase 2 trial, including patients who have less common tumors, are unable to swallow whole pills, and who may wish to try using indoximod in combination with additional chemotherapy options.
Theodore Johnson
This Project By The Numbers
